echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > ICH drafts the principles of modernization of guidelines for clinical trial management (GCP)

    ICH drafts the principles of modernization of guidelines for clinical trial management (GCP)

    • Last Update: 2021-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    On April 19, ICH released the draft of the E6(R3) Clinical Trial Management Practice (GCP) general principles, which will form the basis of its revised GCP guidelines.

    The ICH E6(R3) expert working group is revising the E6(R2) GCP guidelines with a view to applying the GCP principles to the increasingly diversified test types and data sources used to support regulatory and healthcare-related drug decisions.


    Provide flexibility to facilitate the use of technological innovation in clinical trials.


    Since the revision of ICH E6(R2) may have a broad and significant impact on the clinical trial methods in ICH member regions and other regions, the ICH Management Committee stated that it will issue “the latest draft principles in progress” to improve transparency and A common understanding of the issues involved.


    ICH explained that the updated principles are "interdependent and should be considered as a whole to ensure ethical trial behavior, participant safety, and reliable clinical trial results.


    The draft principle document lists 12 main considerations, covering many issues, from ethical considerations, informed consent, quality considerations to the recording of test results.


    The United States-based Association of Clinical Research Organizations (ACRO) welcomed the draft principles, especially the “concerns about innovative digital health technologies and ensuring that the principles of clinical trial execution are synchronized with technological development”.


    The draft document has not yet been publicly consulted.


    GCP refurbishment

    The last revision of the ICH E6(R2) guideline was in 2016.


    When the revision of E6(R2) is completed, the following documents will be available:

    The overall GCP principle document;

    Appendix 1, focusing on interventional clinical trials;

    Appendix 2, will outline other considerations for non-traditional interventional clinical trials.


    The principle document and Appendix 1 are being developed at the same time.







    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.